NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Clinical Trials
2
Data completeness
1/8 — Limited
Drug data last refreshed 49m ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSOL 5% is a protein hydrolysate injectable nutritional product manufactured by AbbVie, designed to provide essential amino acids and nitrogen support. It is indicated for parenteral nutrition in patients unable to meet protein requirements through oral or enteral routes. The product works by delivering pre-digested protein components that can be directly utilized by the body for anabolic support.
Pre-Launch
Pre-launch stage indicates formation of foundational commercial infrastructure; expect lean initial teams focused on hospital/institutional market access and reimbursement establishment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
Started Sep 2025
75 enrolled
Sarcopenia in ElderlyMalnourishedProtein Supplementation+3 more
A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates
Started Mar 2011
86 enrolled
Cow Milk Allergy
Career Relevance
AMINOSOL 5% represents a pre-launch opportunity with career visibility in institutional/hospital sales channels and reimbursement infrastructure. This is an early-stage venture where professionals can shape market positioning and build specialized expertise in parenteral nutrition and hospital formulary dynamics.
Worked on AMINOSOL 5% at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.